Arvinas

New Capabilities

As of May 2026: Receives $50M milestone; co-developer of first approved PROTAC

For 25 years, drug companies have tried to design medicines that destroy harmful proteins outright rather than blocking them. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one.

Updated May 31